OptimizeRx (OPRX) vs Uxin (UXIN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OptimizeRx (OPRX) has outperformed Uxin (UXIN) over the past year, losing 54.1% versus a loss of 66.6%. Over five years, OPRX leads with a -90.1% price change compared with -99.6% for UXIN. Uxin is the larger company by market cap ($246.4 million vs $157.8 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OPRX | UXIN |
|---|---|---|
| Share price | $8.38 | $1.12 |
| Market cap | $157.85M | $246.38M |
| 1-day change | -1.99% | -7.44% |
| YTD return | -31.65% | -66.77% |
| 1-year return | -54.06% | -66.57% |
| 5-year return | -90.10% | -99.55% |
| P/E ratio (TTM) | 34.92 | — |
| Forward P/E | 8.03 | — |
| EPS (TTM) | $0.24 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.25 | $4.18 |
| 52-week low | $4.54 | $0.896 |
| Distance from 52-week high | -62.34% | -73.21% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +50.36% | +132.14% |
| Average volume | 203.38K | 457.04K |
| Shares outstanding | 18.84M | 219.84M |
| Employees | 132 | 2,437 |
| Sector | Healthcare | Consumer Discretionary |
| Industry | Health Information Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OPRX has outperformed UXIN by 12.5 percentage points over the past year.
- The two companies sit in different sectors: OptimizeRx in Healthcare and Uxin in Consumer Discretionary.
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Healthcare · Health Information Services · 132 employees
About Uxin
UXIN stock →Uxin Limited, together with its subsidiaries, operates as a used car retailer in the People's Republic of China. The company offers used car acquisition, inspection, reconditioning, warehousing, pre-sales, and after-sales services; warranty and repair, door-to-door delivery, title transfers, and vehicle registration services; and value-added products and services, such as auto financing options and insurance products.
Consumer Discretionary · Business Services · 2,437 employees
OPRX vs UXIN FAQ
Which is bigger, OptimizeRx or Uxin?
Uxin (UXIN) is larger, with a market capitalization of $246.38M compared with $157.85M for OptimizeRx (OPRX).
Which stock has performed better over the past year, OPRX or UXIN?
OPRX returned -54.06% over the past 12 months, compared with -66.57% for UXIN (price return, excluding dividends). Past performance does not predict future results.
Are OptimizeRx and Uxin in the same industry?
No. OptimizeRx is in the Healthcare sector, while Uxin is in Consumer Discretionary.